Vitamin-C-megaskorbicka-liecba.pdf - Zdravie.sk

Vitamín C a megaskorbická liečba – zabudnutý poklad 374 / 436
Zdroje
[542] Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin
supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 Jul
6;360(9326):23-33. PMID:12114037.
[543] Cook JD, Watson SS, Simpson KM, Lipschitz DA, Skikne BS. The effect of high ascorbic acid
supplementation on body iron stores. Blood. 1984 Sep;64(3):721-6. PMID:6466873.
http://bloodjournal.hematologylibrary.org/cgi/reprint/64/3/721
[544] Bendich A, Cohen M. Ascorbic acid safety: analysis of factors affecting iron absorption. Toxicol Lett. 1990
Apr;51(2):189-201. PMID:2184546. DOI:10.1016/0378-4274(90)90210-D.
[545] Calabrese EJ. Does consumption of mega-doses of ascorbic acid pose a hemolytic risk to persons with sickle
cell trait and sickle cell anemia? Med Hypotheses. 1982 Dec;9(6):647-9. PMID:7167075.
[546] Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sicle cell anemia patients
given vitamin E. Am J Clin Nutr. 1980 May;33(5):968-71. PMID:6154411.
http://www.ajcn.org/cgi/reprint/33/5/968.pdf
[547] Campbell GD, Steinberg MH, Bower JD. Letter: Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann
Intern Med. 1975 Jun;82(6):810. PMID:1138591.
[548] Karunanithy R, Saha N, Ng SE. Serum and red blood cell magnesium, copper, and zinc content in G6PD
deficiency. Am J Hematol. 1990 Oct;35(2):136-8. PMID:239990. DOI:10.1002/ajh.2830350217.
[549] Campbell A, Jack T. Acute reactions to mega ascorbic acid therapy in malignant disease. Scot Med J. 1979
Apr;24(2):151-3. PMID:227054.
[550] Acidum Ascorbicum Biotika, príbalový leták. 2005. Biotika a.s., 976 13 Slovenská Ľupča, Slovenská
Republika. http://www.nobel.sk
[551] The Institute for Optimum Nutrition. Vitamin C – drug interaction.
[552] Sifton DW, ed. Physicians Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2953–4.
[553] Chylack LT Jr, Brown NP, Bron A, Hurst M, Köpcke W, Thien U, Schalch W. The Roche European American
Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant
micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol. 2002 Feb;9(1):49-
80. PMID:11815895.
[554] Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of highdose
supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration
and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001 Oct;119(10):1417-36. PMID:11594942. PMCID:
PMC1462955. NIHMSID: NIHMS9674
[555] Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL,
Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the
prevention of coronary disease. N Engl J Med. 2001 Nov 29;345(22):1583-92. PMID:11757504.
http://content.nejm.org/cgi/content/abstract/345/22/1583
[556] Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC,
Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI. Effects of hormone replacement
therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a
randomized controlled trial. JAMA 2002 Nov 20;288(19):2432-40. PMID:12435256. http://jama.amaassn.org/cgi/reprint/288/19/2432
[557] Hathcock JN. Vitamins and hormone therapy for coronary atherosclerosis. JAMA 2003 Feb 26;289(8):982.
PMID:12597741.
[558] Jialal I, Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water.
Circulation 2003 Feb 25;107(7):926-8. PMID:12600900. http://circ.ahajournals.org/cgi/content/full/107/7/926
[559] Garewal HS, Diplock AT. How 'safe' are antioxidant vitamins? Drug Saf. 1995 Jul;13(1):8-14. PMID:8527021.
Cote INIST : 21755, 35400005172227.0020.
[560] Rivers JM. Safety of high-level vitamin C ingestion. Int J Vitam Nutr Res Suppl. 1989;30:95-102.
PMID:2507711. DOI:10.1111/j.1749-6632.1987.tb23780.x. Cote INIST : 844 B, 35400000316902.0110.
[561] Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment
for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216-
22. PMID:9110909. Cote INIST : 6013, 35400006516851.0040.
http://content.nejm.org/cgi/content/abstract/336/17/1216
[562] Kahaly G, Dienes HP, Beyer J, Hommel G. Randomized, double blind, placebo-controlled trial of low dose
iodide in endemic goiter. J Clin Endocrinol Metab. 1997 Dec;82(12):4049-53. PMID:9398711.
http://jcem.endojournals.org/cgi/reprint/82/12/4049
[563] Diplock AT. Safety of antioxidant vitamins and beta carotene. Am J Clin Nutr. 1995 Dec;62(6 Suppl):1510S-
1516S. PMID:7495252. http://www.ajcn.org/cgi/reprint/62/6/1510S
[564] Balcke P, Schmidt P, Zazgornik J, Kopsa H, Haubenstock A. Ascorbic acid aggravates secondary
hyperoxalemia in patients on chronic hemodialysis. Ann Intern Med. 1984 Sep;101(3):344-5. PMID:6465702.
[565] Scientific Panel on Dietetic Products, Nutrition and Allergies. Opinion of the Scientific Panel on Dietetic
Products, Nutrition and Allergies related to the tolerable upper intake level of vitamin C (L-ascorbic acid, its
calcium, potassium and sodium salts and L-ascorbyl-6-palmitate). Eur Food Safety Authority J. 2004;59:1–21.
[566] Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food. Calcium ascorbate,
magnesium ascorbate and zinc ascorbate added for nutritional purposes in food supplements. (Question No
EFSA-Q-2006-229, EFSA-Q-2005-087, EFSA-Q-2005-104). EFSA Journal. 2009;994:1-22.
http://www.efsa.europa.eu/EFSA/Scientific_Opinion/ans_ej994_Ascorbates_op_en,0.pdf?ssbinary=true
[567] Frei B, Traber M. The new US Dietary Reference Intakes for vitamins C and E. Redox Rep. 2001;6(1):5-9.
PMID:11333117.
[568] Barlett MK et al: NEJM, 226:474, 1942.